Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Mobile-enhanced Transdiagnostic Group Treatment for Adolescents at Risk for Severe Mood Disorders

NCT04887155 is registered in ClinicalTrials.gov with University of California, Los Angeles as lead sponsor.

NCT NCT04887155
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04887155 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Mobile-enhanced Transdiagnostic Group Treatment for Adolescents at Risk for Severe Mood Disorders
Lead sponsor
University of California, Los Angeles
Phase
Not applicable
Overall status
Completed
Start date
August 30, 2021
Completion date
March 15, 2024
Enrollment
91 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

adolescents, mood disorders